General Information
|
|
Product
|
D6 Peptide
|
Description
|
Antigenic Blocking Peptide Atypical chemokine receptor 2 Antibody
|
Verified Applications
|
Immmunodepletion, Competition Assay
|
Host
|
Rabbit
|
Peptide Description
|
Synthetic peptide
|
Accession #
|
NCBI: NP_001287
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
|
Uniprot #
|
O00590
|
Overview
|
Controls chemokine levels and localization via high-affinity chemoking binding that is uncoupled from classic liand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Acts as a regulator of inflammatory leukocyte interactions with lymphatic endothelial cells and is required for immature/mature dendritic cells discrimination.
|
Molecular Function
|
Chemokine Receptor activity; Scavenger receptor activity
|
Subcellular Location
|
Early endosome; Recycling endosome; Cell membrane; Multi-pass membrane protein
|
Expression
|
Endothelial cells lining afferent lympatics in dermis and lymph nodes. Also found n subcapsular and medullary sinuses, tonsillar lympatic sinuses and lymphatics in mucosa and submucosa of appendix, small intestine, and large intestine. Experssed in Kapo
|
Structure
|
C-terminal cytoplasmic tail controls phosphorylation, stability, intracellular trafficking and chemokine scavenging properties.
|
Alternative Nomenclature
|
ACKR2 antibody
Atypical chemokine receptor 2 antibody
Chemokine binding protein 2 antibody
Chemokine receptor CCR 10 antibody
Chemokine receptor CCR 9 antibody
CMKBR9 antibody
|